Margriet Collee

发表

Association analysis identifies 65 new breast cancer risk loci

Gary D Bader, Jaana M. Hartikainen, Jeffery M. Meyer, 2017, Nature.

Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study)

M. Hauptmann, N. Aaronson, A. Maas, 2020, JMIR research protocols.

Effect of a health literacy training program for surgical oncologists and specialized nurses on disparities in referral to breast cancer genetic testing

S. van Dulmen, J. V. D. van der Giessen, M. Hooning, 2021, Breast.

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study

E. Steyerberg, M. Schmidt, M. Adank, 2021, Breast.

Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

D. Easton, A. Antoniou, L. J. Veer, 2013, Journal of Medical Genetics.

Rare variants in XRCC2 as breast cancer susceptibility alleles

F. Couch, J. Benítez, K. Offit, 2012, Journal of Medical Genetics.

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

S. Rosset, W. He, S. Cross, 2023, Journal of Medical Genetics.

TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort

M. Blok, C. V. van Asperen, A. V. D. van den Ouweland, 2019, Familial Cancer.

Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study) (Preprint)

M. Hauptmann, N. Aaronson, A. Maas, 2020 .

A counselee-oriented perspective on risk communication in genetic counseling: Explaining the inaccuracy of the counselees' risk perception shortly after BRCA1/2 test result disclosure

A. Stiggelbout, C. Asperen, J. Oosterwijk, 2011, Genetics in Medicine.

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

C. V. van Asperen, J. Oosterwijk, C. J. Asperen, 2018, British Journal of Cancer.

Epidemiology Ovarian stimulation for IVF and risk of primary breast cancer in BRCA 1 / 2 mutation carriers

J. Oosterwijk, C. J. Asperen, M. Ausems, 2018 .

The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

A. Spurdle, Å. Borg, P. Devilee, 2017, Journal of Medical Genetics.

Online decision support for persons having a genetic predisposition to cancer and their partners during reproductive decision‐making

C. V. van Asperen, J. Oosterwijk, M. Ausems, 2018, Journal of genetic counseling.

Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands

H. Meijers-Heijboer, C. V. van Asperen, J. Oosterwijk, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making

C. V. van Asperen, L. V. van Osch, J. Oosterwijk, 2020, Journal of Community Genetics.

The development of an online decision aid to support persons having a genetic predisposition to cancer and their partners during reproductive decision-making: a usability and pilot study

C. V. van Asperen, L. V. van Osch, J. Oosterwijk, 2018, Familial Cancer.

Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.

A. Stiggelbout, C. V. van Asperen, J. Oosterwijk, 2012, Patient education and counseling.

The counselees' self‐reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters

C. Asperen, J. Oosterwijk, A. Tibben, 2013, Psycho-oncology.